Zobrazeno 1 - 10
of 150
pro vyhledávání: '"Bruno Raynard"'
Autor:
Frédéric Pigneur, Mario Di Palma, Bruno Raynard, Aymeric Guibal, Frédéric Cohen, Nassima Daidj, Richard Aziza, Mostafa El Hajjam, Guillaume Louis, François Goldwasser, Elise Deluche
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 14, Iss 4, Pp 1613-1620 (2023)
Abstract Background A common method for diagnosing sarcopenia involves estimating the muscle mass by computed tomography (CT) via measurements of the cross‐sectional muscle area (CSMA) of all muscles at the third lumbar vertebra (L3) level. Recentl
Externí odkaz:
https://doaj.org/article/3708c139fc82482ca634c135d41b0873
Publikováno v:
Clinical Nutrition Open Science, Vol 48, Iss , Pp 17-26 (2023)
Summary: Medical nutrition therapy is a full-fledged treatment such as antibiotics, antidiabetics or mechanical ventilation. Like any medical procedure, evidence-based medical nutrition therapy (from its indication and introduction, to the eventual i
Externí odkaz:
https://doaj.org/article/0cbfd959dc89497587d0ea7913dda2e7
Autor:
Emeline Colomba, Carolina Alves Costa Silva, Gwénaël Le Teuff, Jamie Elmawieh, Daniel Afonso, Axelle Benchimol‐Zouari, Annalisa Guida, Lisa Derosa, Ronan Flippot, Bruno Raynard, Bernard Escudier, François Bidault, Laurence Albiges
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 13, Iss 5, Pp 2405-2416 (2022)
Abstract Background Cabozantinib, a standard of care metastatic renal cell carcinoma (mRCC), may be associated with weight and muscle loss. These effects of new generation VEGFR tyrosine kinase inhibitor on muscle mass loss are poorly described. Meth
Externí odkaz:
https://doaj.org/article/9c6e69245d384a6088532908f44f179b
Autor:
Antonio Di Meglio, Elise Martin, Tracy E. Crane, Cecile Charles, Aude Barbier, Bruno Raynard, Anthony Mangin, Olivier Tredan, Carole Bouleuc, Paul H. Cottu, Laurence Vanlemmens, Carine Segura-Djezzar, Anne Lesur, Barbara Pistilli, Florence Joly, Thomas Ginsbourger, Bernadette Coquet, Iris Pauporte, Guillemette Jacob, Aude Sirven, Julia Bonastre, Jennifer A. Ligibel, Stefan Michiels, Ines Vaz-Luis
Publikováno v:
Trials, Vol 23, Iss 1, Pp 1-16 (2022)
Abstract Background Elevated body mass index (BMI) represents a risk factor for cancer-related fatigue (CRF). Weight loss interventions are feasible and safe in cancer survivors, leading to improved cardio-metabolic and quality of life (QOL) outcomes
Externí odkaz:
https://doaj.org/article/60d713937f2f49faa05b255c896a13b8
Autor:
Elise Deluche, Denis Lachatre, Mario Di Palma, Hélène Simon, Valentin Tissot, Damien Vansteene, Philippe Meingan, Alexis Mohebi, Grégory Lenczner, Francois Pigneur, Francois Goldwasser, Bruno Raynard
Publikováno v:
Breast, Vol 61, Iss , Pp 84-90 (2022)
Background: Sarcopenia has emerged as an important parameter to predict outcomes and treatment toxicity. However, limited data are available to assess sarcopenia prevalence in metastatic breast cancer and to evaluate its management. Methods: The SCAN
Externí odkaz:
https://doaj.org/article/46720dfaf31e4d23ba28b39368b47170
Autor:
Thomas Hueso, Kenneth Ekpe, Camille Mayeur, Anna Gatse, Marie Joncquel-Chevallier Curt, Guillaume Gricourt, Christophe Rodriguez, Charles Burdet, Guillaume Ulmann, Christel Neut, Salah-Eddine Amini, Patricia Lepage, Bruno Raynard, Christophe Willekens, Jean-Baptiste Micol, Stéphane De Botton, Ibrahim Yakoub-Agha, Frédéric Gottrand, Jean-Luc Desseyn, Muriel Thomas, Paul-Louis Woerther, David Seguy
Publikováno v:
Gut Microbes, Vol 12, Iss 1 (2020)
Induction chemotherapy (7 + 3 regimen) remains the gold standard for patients with acute myeloid leukemia (AML) but is responsible for gut damage leading to several complications such as bloodstream infection (BSI). We aimed to investigate the impact
Externí odkaz:
https://doaj.org/article/3a8868ac050a473ab66abb53e7cb67ff
Autor:
Marie Guinhut, Bruno Raynard
Publikováno v:
Médecine des Maladies Métaboliques. 16:614-619
Publikováno v:
Bulletin du Cancer. 109:516-527
Publikováno v:
Supportive Care in Cancer. 30:3119-3129
Background Cachexia, characterized by involuntary muscle mass loss, negatively impacts survival outcomes, treatment tolerability, and functionality in cancer patients. However, there is a limited appreciation of the true prevalence of low muscle mass
Publikováno v:
Cancers; Volume 14; Issue 14; Pages: 3439
Malnutrition is associated with a greater risk of morbidity and mortality and lower tolerance to chemotherapy. Our purpose was to study the association between nutritional status and the efficiency and tolerance of immunotherapy in non-small cell lun